Vertex Pharmaceuticals | VRTX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 195.44B 5.55B 2026-06
Arrowhead Research USD 11.5B 2.72B 2026-06
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Insmed USD 24.93B 1.82B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 653.61B 42.25B 2026-09
Merck USD 358.5B 41.13B 2026-09
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
United Therapeutics USD 23B 2.19B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06